Stay updated on GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial
Sign up to get notified when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.

Latest updates to the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision entry v3.6.4 was added to the Study Record Versions, updating the historical record to the latest version. The previous entry v3.6.3 was removed as part of this update.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedAdded revision v3.6.3 to the Record History and removed revision v3.6.2. This updates the page’s version history to reflect the latest release.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page now includes an expanded footer with official site links and branding, and the record history section lists past versions and their submission dates.SummaryDifference34%

- Check53 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating enrollment is closed. The page now shows a new release version 'Revision: v3.6.0', replacing the previous 'v3.5.5'.SummaryDifference0.4%

- Check60 days agoChange DetectedA new revision entry, v3.5.5, has been added to the history, replacing the previous revision v3.5.4. This reflects a minor internal update to the site's history presentation.SummaryDifference0.1%

- Check81 days agoChange DetectedThe Record History now lists Revision: v3.5.4 as the latest release, replacing the previous v3.5.3. This reflects a routine site update rather than changes to study records.SummaryDifference0.1%

Stay in the know with updates to GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.